HOLD with mental stop at $319.89; wait for Q3 earnings confirmation before adding capital

• JPM trading $18 below its 50 SMA creates $353 in overhead resistance requiring absorption
• MACD at negative 4.40 with histogram expanding in negative territory at minus 1.82 shows accelerating downside momentum
• Trading securities portfolio grew 58 percent in 18 months to $794 billion creating duration risk
• Loan growth of 14.5 percent YoY with net loans expanding from $1.32 trillion to $1.52 trillion in 18 months is aggressive for late-cycle
• Mortgage rates at 7.58 percent crushing housing-related credit
• 30-year yield at highest level since 2002 creating mark-to-market losses on duration-heavy balance sheet
• Q3 EPS base effect: $4.39 billion in special items could make Q3 optically weak vs Q2's $7.70
• Aggressive scale-in tranches at $333-335 and $325-328 create blended entry around $330; break below $319.89 risks 10-15 percent additional downside from stop-loss cascades
• Conservative risk-reward assessment: 65-70 percent probability of $319.89 holding yields 1.5-to-1 not 4-to-1

→ vs aggressive: Moving average anchoring is not circular reasoning; 50 SMA represents institutional cost basis that creates forced selling when breached

→ vs aggressive: Bollinger Band oversold buys are survivorship bias; MACD negative 4.40 with histogram minus 1.82 shows accelerating downside with no bullish divergence confirmed

→ vs aggressive: Curve benefit thesis ignores duration pain; 30-year yield at highest since 2002 hammers mark-to-market on $794 billion trading portfolio

→ vs aggressive: Credit risk absent from aggressive case; 14.5% loan growth in late-cycle with Moody's Zandi warning of rate damage is serious oversight

→ vs aggressive: 4-to-1 risk-reward is fabricated; realistic probability suggests 1.5-to-1 given momentum deterioration, credit risks, and earnings uncertainty

Hold existing position; add modest starter tranche sized at 25-35% of normal allocation near current levels; 200 SMA at 319.89 as structural invalidation; add conditions: daily close above 342 with RSI confirmation, or successful test-and-hold of lower Bollinger Band with bullish divergence

• Fundamental profile is elite: 17.8% ROE, 18% four-year EPS CAGR, 13.4x forward P/E, 5.9% total shareholder yield
• Macro tailwind: 30-year yield at highest since 2002 with Polymarket pricing 96% probability of zero Fed cuts in 2026
• Technical probability of 200 SMA holding is 65-70%, not the aggressive analyst's implied 80% (MACD at negative 4.40, histogram expanding negative at minus 1.82)
• Duration risk: trading securities portfolio grew 58% in 18 months to $794 billion, creating mark-to-market exposure
• Credit risk legitimate: loan growth 14.5% YoY with mortgage rates at 7.58% in late-cycle environment
• Key technical levels: 50 SMA at 353.18, 200 SMA at 319.89, lower Bollinger Band at 333.22, RSI at 34.72
• Risk per share on starter position: roughly $15 or 4.5%
• Do not add aggressively below current levels or chase flush toward 325 until confirmation signals appear
• Quiet sentiment (zero news flow, zero community chatter) indicates no sentiment edge, supporting reliance on fundamentals and technicals

→ vs aggressive: Framing as 4-to-1 risk-reward requires 80% probability that MACD data (negative 4.40, histogram expanding at minus 1.82) does not support; honest read is 65-70%

→ vs aggressive: Duration risk from trading securities portfolio growing 58% to $794 billion creates mark-to-market pain with 30-year yields at 2002 highs; complete picture requires acknowledging this exposure

→ vs conservative: 50 SMA at 353.18 is not a hard ceiling; elevated supply from institutional cost basis gets absorbed in high-quality names

→ vs conservative: Treating entire zone between current price and 319.89 as no-man's land ignores lower Bollinger Band at 333.22 as structurally meaningful level that already absorbed selling

→ vs conservative: Being overly patient with hard line waiting for break above 342 misses window where risk-reward is most attractive on a compounder